Disease The intractable diseases designated by MHLW, Japan
Diseases : 348 - Clinical trials : 43,690 / Drugs : 27,527 - ( DrugBank : 2,441 ) / Drug target genes : 714 - Drug target pathways : 315
| ID | Disease name [Group] | Clinical trial Phase 1 / 2 / 3 / 4 | Drug [ DrugBank ] | Target gene Target pathway | Domestic patients Med expenses recipients, FY2024 (corrected) |
|---|---|---|---|---|---|
| 181 | Crouzon syndrome [Hear] 💬 | 1 1 trial | 0 / 0 / 0 / 0 💬 | 1 1 drug [ 0 - ] | 0 - | 22 22 patientsAge distribution
|
| 182 | Apert syndrome [Hear] 💬 | 1 1 trial | 0 / 0 / 0 / 0 💬 | 1 1 drug [ 0 - ] | 0 - | 10 10 patientsAge distribution
|
| 183 | Pfeiffer syndrome [Hear] 💬 | 1 1 trial | 0 / 0 / 0 / 0 💬 | 1 1 drug [ 0 - ] | 0 - | 10 10 patientsAge distribution
|
| 184 | Antley-Bixler syndrome [Hear] 💬 | 0 - | 0 - | 0 - | 3 3 patientsAge distribution
|
| 190 | Branchio-oto-renal syndrome [Hear] 💬 "BOR syndrome" | 0 - | 0 - | 0 - | 7 7 patientsAge distribution
|
| 303 | Usher syndrome [Hear] 💬 [Eye] 💬 | 16 16 trials | 1 / 2 / 0 / 0 💬 | 27 27 drugs [ 6 6 drugs ] | 1 1 gene 1 pathway | 30 30 patientsAge distribution
|
| 304 | Juvenile-onset bilateral sensorineural hearing loss [Hear] 💬 "Bilateral sudden sensorineural hearing loss" | 0 - | 0 - | 0 - | 70 70 patientsAge distribution
|
| 305 | Delayed endolymphatic hydrops [Hear] 💬 | 2 2 trials | 0 / 0 / 0 / 0 💬 | 2 2 drugs [ 2 2 drugs ] | 0 - | 28 28 patientsAge distribution
|
| 306 | Eosinophilic sinusitis [Imm] 💬 [Hear] 💬 | 2 2 trials | 0 / 0 / 0 / 1 💬 | 4 4 drugs [ 4 4 drugs ] | 3 3 genes 19 pathways | 34535 34,535 patientsAge distribution
|
| 330 | Congenital tracheal stenosis [Resp] 💬 [Hear] 💬 "Congenital subglottic stenosis", "Congenital tracheal stenosis", "Congenital subglottic stenosis" | 2 2 trials | 0 / 1 / 0 / 0 💬 | 3 3 drugs [ 2 2 drugs ] | 0 - | 68 68 patientsAge distribution
|
